![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 17beta-estradiol | multiple interactions | ISO | RGD:1316133 | 6480464 | [Estradiol co-treated with TGFB1 protein] results in increased expression of KCTD11 mRNA | CTD | PMID:30165855 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1316133 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of KCTD11 mRNA | CTD | PMID:30096437 | 2-hydroxypropanoic acid | decreases expression | ISO | RGD:1316133 | 6480464 | Lactic Acid results in decreased expression of KCTD11 mRNA | CTD | PMID:30851411 | 6-propyl-2-thiouracil | decreases expression | ISO | RGD:1307125 | 6480464 | Propylthiouracil results in decreased expression of KCTD11 mRNA | CTD | PMID:24780913 | aflatoxin B1 | increases expression | ISO | RGD:1316133 | 6480464 | Aflatoxin B1 results in increased expression of KCTD11 mRNA | CTD | PMID:21641981, PMID:22100608 | all-trans-retinoic acid | increases expression | ISO | RGD:1316133 | 6480464 | Tretinoin results in increased expression of KCTD11 mRNA | CTD | PMID:23724009 | amphetamine | increases expression | ISO | RGD:1307125 | 6480464 | Amphetamine results in increased expression of KCTD11 mRNA | CTD | PMID:30779732 | avobenzone | decreases expression | ISO | RGD:1316133 | 6480464 | avobenzone results in decreased expression of KCTD11 mRNA | CTD | PMID:31016361 | benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzoapyrene results in increased expression of KCTD11 mRNA | CTD | PMID:25908611 | benzo[a]pyrene | decreases methylation | ISO | RGD:1316133 | 6480464 | Benzoapyrene results in decreased methylation of KCTD11 3' UTR | CTD | PMID:27901495 | benzo[a]pyrene | affects methylation | ISO | RGD:1316133 | 6480464 | Benzoapyrene affects the methylation of KCTD11 promoter | CTD | PMID:27901495 | bis(2-ethylhexyl) phthalate | increases expression | ISO | RGD:1316133 | 6480464 | Diethylhexyl Phthalate results in increased expression of KCTD11 mRNA | CTD | PMID:31163220 | bisphenol A | increases expression | ISO | RGD:1307125 | 6480464 | bisphenol A results in increased expression of KCTD11 mRNA | CTD | PMID:25181051 | cadmium dichloride | affects expression | EXP | | 6480464 | Cadmium Chloride affects the expression of KCTD11 mRNA | CTD | PMID:18974090 | carbon nanotube | increases expression | EXP | | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | choline | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of KCTD11 gene | CTD | PMID:20938992 | cisplatin | increases expression | ISO | RGD:1316133 | 6480464 | Cisplatin results in increased expression of KCTD11 mRNA | CTD | PMID:27392435 | dioxygen | increases expression | ISO | RGD:1316133 | 6480464 | Oxygen deficiency results in increased expression of KCTD11 mRNA | CTD | PMID:20042640 | dioxygen | multiple interactions | EXP | | 6480464 | [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of KCTD11 mRNA | CTD | PMID:30529165 | dorsomorphin | multiple interactions | ISO | RGD:1316133 | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in decreased expression of KCTD11 mRNA | CTD | PMID:27188386 | ethyl methanesulfonate | increases expression | ISO | RGD:1316133 | 6480464 | Ethyl Methanesulfonate results in increased expression of KCTD11 mRNA | CTD | PMID:23649840 | folic acid | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of KCTD11 gene | CTD | PMID:20938992 | folic acid | increases expression | EXP | | 6480464 | Folic Acid results in increased expression of KCTD11 mRNA | CTD | PMID:25629700 | L-methionine | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of KCTD11 gene | CTD | PMID:20938992 | methyl methanesulfonate | increases expression | ISO | RGD:1316133 | 6480464 | Methyl Methanesulfonate results in increased expression of KCTD11 mRNA | CTD | PMID:23649840 | paracetamol | affects expression | EXP | | 6480464 | Acetaminophen affects the expression of KCTD11 mRNA | CTD | PMID:17562736 | paracetamol | increases expression | ISO | RGD:1316133 | 6480464 | Acetaminophen results in increased expression of KCTD11 mRNA | CTD | PMID:22230336 | pirinixic acid | multiple interactions | EXP | | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of KCTD11 mRNA | CTD | PMID:19710929 | rac-lactic acid | decreases expression | ISO | RGD:1316133 | 6480464 | Lactic Acid results in decreased expression of KCTD11 mRNA | CTD | PMID:30851411 | SB 431542 | multiple interactions | ISO | RGD:1316133 | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in decreased expression of KCTD11 mRNA | CTD | PMID:27188386 | silver atom | increases expression | ISO | RGD:1316133 | 6480464 | Silver results in increased expression of KCTD11 mRNA | CTD | PMID:26014281 | silver(0) | increases expression | ISO | RGD:1316133 | 6480464 | Silver results in increased expression of KCTD11 mRNA | CTD | PMID:26014281 | sodium dodecyl sulfate | decreases expression | ISO | RGD:1316133 | 6480464 | Sodium Dodecyl Sulfate results in decreased expression of KCTD11 mRNA | CTD | PMID:31734321 | trichostatin A | decreases expression | ISO | RGD:1316133 | 6480464 | trichostatin A results in decreased expression of KCTD11 mRNA | CTD | PMID:24935251 | urethane | decreases expression | ISO | RGD:1316133 | 6480464 | Urethane results in decreased expression of KCTD11 mRNA | CTD | PMID:28818685 | valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of KCTD11 mRNA | CTD | PMID:19136453 | valproic acid | affects expression | ISO | RGD:1316133 | 6480464 | Valproic Acid affects the expression of KCTD11 mRNA | CTD | PMID:25979313 | valproic acid | decreases expression | ISO | RGD:1316133 | 6480464 | Valproic Acid results in decreased expression of KCTD11 mRNA | CTD | PMID:23179753, PMID:26272509 | valproic acid | multiple interactions | ISO | RGD:1316133 | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in decreased expression of KCTD11 mRNA | CTD | PMID:27188386 | |